Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice (Q46579468)
Jump to navigation
Jump to search
scientific article published on 10 April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice |
scientific article published on 10 April 2008 |
Statements
1 reference
Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice (English)
1 reference
Koji Takeuchi
1 reference
Tomoko Asakawa
1 reference
Osamu Kataoka
1 reference
Hiroyuki Odaka
1 reference
10 April 2008
1 reference
1 reference
588
1 reference
2-3
1 reference
325-332
1 reference
Identifiers
1 reference
1 reference